Fosamax

Defective Drug Lawyers: Fosamax

A minor trauma such as a tooth extraction can trigger the onset of a disease that kills the jaw bone in people who take the osteoporosis drug Fosamax (alendronate).

In this severe jaw condition known as osteonecrosis of the jaw (ONJ or "dead jaw") the jaw bone dies and is unable to regenerate, eventually leading to extreme pain and exposed bone in the mouth. After this bone death, the dead bone tissue must be surgically removed, which can cause facial disfigurement.

Passionate Representation, Historic Results
Contact Hersh & Hersh: 1-800-441-5545

Fosamax is a bisphosphonate that is prescribed widely to prevent bone loss or the decrease of bone density. It is commonly used to prevent or treat osteoporosis.

The American Association of Endodontists released a position paper stating that many patients who take Fosamax may be at risk for developing this terrible complication.

For years Merck, the pharmaceutical company that makes Fosamax, failed to adequately warn patients and doctors that the drug could limit blood flow to the jaw, and result in osteonecrosis.

If you or a member of your family has developed osteonecrosis after taking Fosamax, please contact a defective drug attorney at Hersh & Hersh today. We offer a free consultation to discuss your case and advise you of your legal rights and options. If you select us as your legal representative, you will pay no legal fees unless we win financial compensation for your medical bills, pain and suffering, lost wages and other damages.

From our offices in San Francisco, California, the lawyers of Hersh & Hersh represent clients injured by Fosamax and other defective and dangerous drugs throughout the nation.